Home Newsfeeds Scotiabank Downgrades Saputo to Sector Perform, Lowers Price Target to C$37

Scotiabank Downgrades Saputo to Sector Perform, Lowers Price Target to C$37

Scotiabank analyst George Doumet downgrades Saputo (TSX:SAP) from Sector Outperform to Sector Perform and lowers the price target from C$40 to C$37.

byBenzinga Newsdesk

October 3, 2022

1 minute read

Scotiabank analyst George Doumet downgrades Saputo (TSX:SAP) from Sector Outperform to Sector Perform and lowers the price target from C$40 to C$37.

News

‘Polestar To Supply Batteries For Candela’s “Flying” Electric Boats’ -InsideEVs Report

By Benzinga Newsdesk

August 23, 1:15 PM

https://insideevs.com/news/606058/polestar-supply-batteries-candela-flying-electric-boats/

PSNY

Khalifa Kush Products Coming To Massachusetts Cannabis Consumers Via Cresco Labs

By Vuk Zdinjak

July 20, 8:14 AM

Cresco Labs (OTCQX: CRLBF) (CSE:CL) (FSE:6CQ) expanded its partnership with Khalifa Kush to exclusively cultivate, manufacture and distribute the cannabis brand’s products in Massachusetts.

CRLBF

Morgan Stanley Almost Triples Abercrombie & Fitch Price Target To Imply It’s Fairly Valued – Read Why

By Shivani Kumaresan

August 25, 12:47 PM

Morgan Stanley analyst Alex Straton upgraded the shares of Abercrombie & Fitch Co (NYSE: ANF)

ANF

Why Revolution Medicines Shares Are Trading Higher Today

By Sean Torres

February 28, 4:49 PM

Revolution Medicines, Inc. (NASDAQ: RMVD) shares are trading higher after the company reported better-than-expected fourth-quarter results.

RMVD

Scotiabank Downgrades Saputo to Sector Perform, Lowers Price Target to C$37

Related Posts

‘Polestar To Supply Batteries For Candela’s “Flying” Electric Boats’ -InsideEVs Report

Khalifa Kush Products Coming To Massachusetts Cannabis Consumers Via Cresco Labs

Morgan Stanley Almost Triples Abercrombie & Fitch Price Target To Imply It’s Fairly Valued – Read Why

Why Revolution Medicines Shares Are Trading Higher Today